• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • Accolate® (zafirlukast)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Accolate® (zafirlukast)

Alternative brand (trade) names: Vanticon and Accoleit

What is Accolate® ?

Accolate is an anti-inflammatory agent, and is called a leukotriene antagonist; it contains the medicine zafirlukast.

What is Accolate® used for?

Accolate is used to treat long-term asthma and to help prevent asthma attacks. It is intended for use in patients who require more than an occasional “puff” of a bronchodilator (medicine which widens the air passages) for control of their symptoms.

How does Accolate® work ?

Accolate works by directly blocking substances called leukotrienes, which are molecules that contribute to inflammation and narrowing in the airways, a process that leads to symptoms such as difficulty in breathing in patients with asthma. The action of Accolate reduces this inflammation and thus helps to control the symptoms of asthma, and improves lung function.

Even if symptoms are not present, you should keep taking Accolate so it can continue to block the leukotrienes and help give you more control of potential asthma symptoms.

How is Accolate® given ?

Accolate is a tablet that you take twice daily (in the morning and evening) to help control asthma symptoms all day and all night.

Country specific information

To consult your local information.

Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Read more important information.

Back to search

  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009